R

ise and shine, everyone, another busy day is on the way. We could tell because our short person rushed out the door to grab a ride to the local schoolhouse and we have already quaffed two cups of stimulation — French toast is our preference, for those tracking such things. All this means that the time has come to attack the ever-growing to-do list. So join us as we dig in. Speaking of which, here are some tidbits. Hope your day is outstanding …

The World Health Organization hopes to conduct a “full review” by the end of the year of data on the Sanofi (SNY) dengue vaccine, Reuters reports. The move comes after the company said a new analysis found its Dengvaxia vaccine could actually make future cases of the mosquito-borne virus more severe in people who were not previously infected. The issue arises after a pair of scientific papers published over the past two years suggested such a problem with the vaccine.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.